References

Eosinophilic Esophagitis

10.1001/jama.2021.14920 · ExternalCitation · doi-reference

Eosinophilic Esophagitis in the Middle East: Insight From a Comprehensive Systematic Review

10.1002/jgh3.70305 · ExternalCitation · doi-reference

Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme

10.1002/ueg2.12220 · ExternalCitation · doi-reference

Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry

10.1002/ueg2.12240 · ExternalCitation · doi-reference

Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry

10.1002/ueg2.12533 · ExternalCitation · doi-reference

Esophageal eosinophilia with dysphagia

10.1007/bf01296781 · ExternalCitation · doi-reference

Eosinophilic esophagitis: An underdiagnosed cause of dysphagia and food impaction to be recognized by otolaryngologists

10.1007/s00106-018-0516-3 · ExternalCitation · doi-reference

Diagnosis and management of eosinophilic esophagitis and esophageal food impaction in adults

10.1007/s00508-024-02401-w · ExternalCitation · doi-reference

Esophageal dysmotility in patients with eosinophilic esophagitis: Pathogenesis, assessment tools, manometric characteristics, and clinical implications

10.1007/s10388-022-00964-z · ExternalCitation · doi-reference

Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis

10.1007/s10620-009-0859-4 · ExternalCitation · doi-reference

Montelukast Was Inefficient in Maintaining Steroid-Induced Remission in Adult Eosinophilic Esophagitis

10.1007/s10620-011-1775-y · ExternalCitation · doi-reference

Esophageal Food Impaction and Eosinophilic Esophagitis: A Retrospective Study, Systematic Review, and Meta-Analysis

10.1007/s10620-015-3723-8 · ExternalCitation · doi-reference

Assessing Adherence and Barriers to Long-Term Elimination Diet Therapy in Adults with Eosinophilic Esophagitis

10.1007/s10620-018-5045-0 · ExternalCitation · doi-reference

Motivations, Barriers, and Outcomes of Patient-Reported Shared Decision Making in Eosinophilic Esophagitis

10.1007/s10620-020-06438-5 · ExternalCitation · doi-reference

Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis: Predictors of Nonresponse

10.1007/s10620-020-06633-4 · ExternalCitation · doi-reference

Allergies Come Clean: The Role of Detergents in Epithelial Barrier Dysfunction

10.1007/s11882-023-01094-x · ExternalCitation · doi-reference

Eosinophilic Esophagitis: Mechanisms of Disease and Approach to Treatment

10.1007/s11882-026-01253-w · ExternalCitation · doi-reference

Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications

10.1007/s12016-019-08733-0 · ExternalCitation · doi-reference

Documenting the Journey of Patients with Eosinophilic Esophagitis and the Impact of the Disease on Patients and their Caregivers: A Cross-sectional, Qualitative Research Study

10.1007/s12325-020-01463-2 · ExternalCitation · doi-reference

Association between atopic manifestations and eosinophilic esophagitis

10.1016/j.anai.2017.02.006 · ExternalCitation · doi-reference

Is eosinophilic esophagitis a member of the atopic march?

10.1016/j.anai.2017.10.003 · ExternalCitation · doi-reference

Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens

10.1016/j.anai.2018.12.013 · ExternalCitation · doi-reference

Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use

10.1016/j.anai.2022.01.019 · ExternalCitation · doi-reference

Breaking down the complex pathophysiology of eosinophilic esophagitis

10.1016/j.anai.2022.10.026 · ExternalCitation · doi-reference

Clinical guidance for the use of dupilumab in eosinophilic esophagitis

10.1016/j.anai.2022.12.014 · ExternalCitation · doi-reference

Food elimination diets in eosinophilic esophagitis: Practical tips in current management and future directions

10.1016/j.bpg.2023.101825 · ExternalCitation · doi-reference

Comparison of Oral Prednisone and Topical Fluticasone in the Treatment of Eosinophilic Esophagitis: A Randomized Trial in Children

10.1016/j.cgh.2007.11.008 · ExternalCitation · doi-reference

Epidemiology of Eosinophilic Esophagitis Over Three Decades in Olmsted County, Minnesota

10.1016/j.cgh.2009.06.023 · ExternalCitation · doi-reference

Clinical, Endoscopic, and Histologic Findings Distinguish Eosinophilic Esophagitis From Gastroesophageal Reflux Disease

10.1016/j.cgh.2009.08.030 · ExternalCitation · doi-reference

Esophageal Eosinophilic Infiltration Responds to Proton Pump Inhibition in Most Adults

10.1016/j.cgh.2010.09.019 · ExternalCitation · doi-reference

Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients with Eosinophilic Esophagitis

10.1016/j.cgh.2011.01.017 · ExternalCitation · doi-reference

Achalasia with Dense Eosinophilic Infiltrate Responds to Steroid Therapy

10.1016/j.cgh.2011.08.002 · ExternalCitation · doi-reference

The Prevalence and Diagnostic Utility of Endoscopic Features of Eosinophilic Esophagitis: A Meta-analysis

10.1016/j.cgh.2012.04.019 · ExternalCitation · doi-reference

Food Allergy Testing in Eosinophilic Esophagitis: What the Gastroenterologist Needs to Know

10.1016/j.cgh.2013.09.007 · ExternalCitation · doi-reference

Prevalence of Eosinophilic Esophagitis in the United States

10.1016/j.cgh.2013.09.008 · ExternalCitation · doi-reference

Proton Pump Inhibitors Partially Restore Mucosal Integrity in Patients with Proton Pump Inhibitor–Responsive Esophageal Eosinophilia but Not Eosinophilic Esophagitis

10.1016/j.cgh.2014.02.037 · ExternalCitation · doi-reference

Effects of Topical Steroids on Tight Junction Proteins and Spongiosis in Esophageal Epithelia of Patients with Eosinophilic Esophagitis

10.1016/j.cgh.2014.02.039 · ExternalCitation · doi-reference

Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients with Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis

10.1016/j.cgh.2015.07.041 · ExternalCitation · doi-reference

Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment

10.1016/j.cgh.2015.08.040 · ExternalCitation · doi-reference

Health-Related Quality of Life and Costs Associated with Eosinophilic Esophagitis: A Systematic Review

10.1016/j.cgh.2017.06.036 · ExternalCitation · doi-reference

Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children

10.1016/j.cgh.2017.12.019 · ExternalCitation · doi-reference

Maintenance Treatment Of Eosinophilic Esophagitis with Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients

10.1016/j.cgh.2018.05.045 · ExternalCitation · doi-reference

Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients with Eosinophilic Esophagitis

10.1016/j.cgh.2018.05.051 · ExternalCitation · doi-reference

Analysis of Midesophageal Biopsies Increases Sensitivity of Detection of Eosinophilic Esophagitis

10.1016/j.cgh.2018.09.019 · ExternalCitation · doi-reference

A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis

10.1016/j.cgh.2019.01.030 · ExternalCitation · doi-reference

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial

10.1016/j.cgh.2019.08.050 · ExternalCitation · doi-reference

Persistent Basal Cell Hyperplasia Is Associated with Clinical and Endoscopic Findings in Patients with Histologically Inactive Eosinophilic Esophagitis

10.1016/j.cgh.2019.08.055 · ExternalCitation · doi-reference

A Model Using Clinical and Endoscopic Characteristics Identifies Patients at Risk for Eosinophilic Esophagitis According to Updated Diagnostic Guidelines

10.1016/j.cgh.2020.06.068 · ExternalCitation · doi-reference

Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients with Eosinophilic Esophagitis

10.1016/j.cgh.2020.07.056 · ExternalCitation · doi-reference

STAT6 Variants Associate with Relapse of Eosinophilic Esophagitis in Patients Receiving Long-term Proton Pump Inhibitor Therapy

10.1016/j.cgh.2020.08.020 · ExternalCitation · doi-reference

Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study

10.1016/j.cgh.2020.08.027 · ExternalCitation · doi-reference

Budesonide Oral Suspension Improves Outcomes in Patients with Eosinophilic Esophagitis: Results From a Phase 3 Trial

10.1016/j.cgh.2021.04.022 · ExternalCitation · doi-reference

Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults with Eosinophilic Esophagitis

10.1016/j.cgh.2021.05.049 · ExternalCitation · doi-reference

Multidisciplinary Eosinophilic Esophagitis Care: A Model for Comprehensive Patient-Centered Care Through Shared Decision Making Between Gastroenterology, Allergy, and Nutrition

10.1016/j.cgh.2021.07.025 · ExternalCitation · doi-reference

A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients

10.1016/j.cgh.2021.10.028 · ExternalCitation · doi-reference

Improving the Diagnostic Yield of High-Resolution Esophageal Manometry for GERD: The “Straight Leg-Raise” International Study

10.1016/j.cgh.2022.10.008 · ExternalCitation · doi-reference

Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis

10.1016/j.cgh.2023.03.006 · ExternalCitation · doi-reference

A Newly Proposed Severity Index for Eosinophilic Esophagitis is Associated with Baseline Clinical Features and Successful Treatment Response

10.1016/j.cgh.2023.03.047 · ExternalCitation · doi-reference

Epidemiologic Burden and Projections for Eosinophilic Esophagitis–Associated Emergency Department Visits in the United States: 2009–2030

10.1016/j.cgh.2023.04.028 · ExternalCitation · doi-reference

Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976–2022: A Systematic Review and Meta-analysis

10.1016/j.cgh.2023.06.005 · ExternalCitation · doi-reference

Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients with Eosinophilic Esophagitis

10.1016/j.cgh.2023.08.015 · ExternalCitation · doi-reference

The Index of Severity for Eosinophilic Esophagitis (I-SEE) Reflects Longitudinal Clinicopathologic Changes in Children

10.1016/j.cgh.2023.09.015 · ExternalCitation · doi-reference

Prevalence and Costs of Eosinophilic Esophagitis in the United States

10.1016/j.cgh.2024.09.031 · ExternalCitation · doi-reference

Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension Study

10.1016/j.cgh.2024.10.034 · ExternalCitation · doi-reference

Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis

10.1016/j.dld.2015.08.013 · ExternalCitation · doi-reference

Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE)

10.1016/j.dld.2016.11.012 · ExternalCitation · doi-reference

Diagnostic delay and misdiagnosis in eosinophilic oesophagitis

10.1016/j.dld.2021.05.017 · ExternalCitation · doi-reference

Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis

10.1016/j.dld.2021.05.025 · ExternalCitation · doi-reference

Systematic Review: Esophageal motility patterns in patients with eosinophilic esophagitis

10.1016/j.dld.2022.01.003 · ExternalCitation · doi-reference

Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials

10.1016/j.dld.2022.05.004 · ExternalCitation · doi-reference

Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry

10.1016/j.dld.2022.09.020 · ExternalCitation · doi-reference

The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis—Definition, Clinical Presentation and Diagnosis

10.1016/j.dld.2024.02.005 · ExternalCitation · doi-reference

The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring

10.1016/j.dld.2024.02.020 · ExternalCitation · doi-reference

Course of Esophageal Strictures in Eosinophilic Esophagitis Using Structured Esophagram Protocol

10.1016/j.gastha.2024.01.010 · ExternalCitation · doi-reference

Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis

10.1016/j.gie.2006.04.037 · ExternalCitation · doi-reference

Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis

10.1016/j.gie.2010.09.036 · ExternalCitation · doi-reference

Esophageal foreign-body impactions: Epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis

10.1016/j.gie.2011.06.029 · ExternalCitation · doi-reference

A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease

10.1016/j.gie.2013.10.027 · ExternalCitation · doi-reference

Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: A systematic review and meta-analysis

10.1016/j.gie.2017.04.028 · ExternalCitation · doi-reference

Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference

10.1016/j.gie.2022.05.013 · ExternalCitation · doi-reference

Association between time from esophageal food impaction to endoscopy and adverse events

10.1016/j.gie.2023.11.005 · ExternalCitation · doi-reference

Pathophysiology and Clinical Impact of Esophageal Remodeling and Fibrosis in Eosinophilic Esophagitis

10.1016/j.iac.2023.12.002 · ExternalCitation · doi-reference

Histopathology of Eosinophilic Esophagitis

10.1016/j.iac.2023.12.008 · ExternalCitation · doi-reference

Prevalence of atopic comorbidities in eosinophilic esophagitis: A case-control study of 449 patients

10.1016/j.jaad.2016.08.068 · ExternalCitation · doi-reference

IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids

10.1016/j.jaci.2007.10.024 · ExternalCitation · doi-reference

Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland

10.1016/j.jaci.2011.09.013 · ExternalCitation · doi-reference

Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet

10.1016/j.jaci.2012.05.021 · ExternalCitation · doi-reference

Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: A prospective study on the food cause of the disease

10.1016/j.jaci.2012.12.664 · ExternalCitation · doi-reference

Proton pump inhibitor–responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis

10.1016/j.jaci.2015.07.008 · ExternalCitation · doi-reference

Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis

10.1016/j.jaci.2015.07.033 · ExternalCitation · doi-reference

Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study

10.1016/j.jaci.2017.08.038 · ExternalCitation · doi-reference

Dietary therapy for eosinophilic esophagitis

10.1016/j.jaci.2018.02.028 · ExternalCitation · doi-reference

Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites

10.1016/j.jaci.2018.05.014 · ExternalCitation · doi-reference

Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α

10.1016/j.jaci.2018.10.067 · ExternalCitation · doi-reference

Diagnosis and treatment of eosinophilic esophagitis

10.1016/j.jaci.2019.11.011 · ExternalCitation · doi-reference

2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group

10.1016/j.jaci.2020.10.003 · ExternalCitation · doi-reference

Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13

10.1016/j.jaci.2024.01.017 · ExternalCitation · doi-reference

Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis

10.1016/j.jaci.2024.04.025 · ExternalCitation · doi-reference

Dietary Therapy and Nutrition Management of Eosinophilic Esophagitis: A Work Group Report of the American Academy of Allergy, Asthma, and Immunology

10.1016/j.jaip.2016.12.026 · ExternalCitation · doi-reference

Eosinophilic Esophagitis Is a Late Manifestation of the Allergic March

10.1016/j.jaip.2018.05.010 · ExternalCitation · doi-reference

Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research

10.1016/j.jaip.2018.05.038 · ExternalCitation · doi-reference

Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management

10.1016/j.jaip.2018.06.012 · ExternalCitation · doi-reference

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes

10.1016/j.jaip.2021.10.001 · ExternalCitation · doi-reference

Ethical Implications of Continuing Oral Immunotherapy After the Development of Eosinophilic Esophagitis

10.1016/j.jaip.2023.08.012 · ExternalCitation · doi-reference

Artificial Intelligence Tools for the Diagnosis of Eosinophilic Esophagitis in Adults Reporting Dysphagia: Development, External Validation, and Software Creation for Point-of-Care Use

10.1016/j.jaip.2023.12.031 · ExternalCitation · doi-reference

Mo1228 Dupilumab normalizes the eosinophilic esophagitis disease transcriptome in adult patients with eosinophilic esophagitis

10.1016/s0016-5085(20)32766-9 · ExternalCitation · doi-reference

Association of eosinophilic inflammation with esophageal food impaction in adults

10.1016/s0016-5107(05)00313-5 · ExternalCitation · doi-reference

One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: A multicentre, randomised, open-label trial

10.1016/s2468-1253(23)00012-2 · ExternalCitation · doi-reference

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

10.1016/s2468-1253(23)00204-2 · ExternalCitation · doi-reference

Seasonal Distribution in Newly Diagnosed Cases of Eosinophilic Esophagitis in Adults

10.1038/ajg.2008.169 · ExternalCitation · doi-reference

Esophageal Dilation in Eosinophilic Esophagitis: Effectiveness, Safety, and Impact on the Underlying Inflammation

10.1038/ajg.2009.657 · ExternalCitation · doi-reference

Randomized Controlled Trial Comparing Aerosolized Swallowed Fluticasone to Esomeprazole for Esophageal Eosinophilia

10.1038/ajg.2012.443 · ExternalCitation · doi-reference

Elemental Diet Induces Histologic Response in Adult Eosinophilic Esophagitis

10.1038/ajg.2012.468 · ExternalCitation · doi-reference

Clinical and Endoscopic Characteristics do Not Reliably Differentiate PPI-Responsive Esophageal Eosinophilia and Eosinophilic Esophagitis in Patients Undergoing Upper Endoscopy: A Prospective Cohort Study

10.1038/ajg.2013.363 · ExternalCitation · doi-reference

The Optimal Number of Biopsy Fragments to Establish a Morphologic Diagnosis of Eosinophilic Esophagitis

10.1038/ajg.2013.463 · ExternalCitation · doi-reference

Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis

10.1038/ajg.2015.314 · ExternalCitation · doi-reference

Long-Term Treatment of Eosinophilic Esophagitis with Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept

10.1038/ajg.2017.202 · ExternalCitation · doi-reference

Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis

10.1038/ajg.2017.363 · ExternalCitation · doi-reference

Early Comparison of Inflammatory vs. Fibrostenotic Phenotype in Eosinophilic Esophagitis in a Multicenter Longitudinal Study

10.1038/ctg.2015.62 · ExternalCitation · doi-reference

Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy

10.1038/modpathol.2014.110 · ExternalCitation · doi-reference

Helicobacter Pylori Infection Does Not Protect Against Eosinophilic Esophagitis: Results From a Large Multicenter Case-Control Study

10.1038/s41395-018-0035-6 · ExternalCitation · doi-reference

The Natural Course of Eosinophilic Esophagitis and Long-Term Consequences of Undiagnosed Disease in a Large Cohort

10.1038/s41395-018-0052-5 · ExternalCitation · doi-reference

Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis— Current Concepts and Perspectives for Steroid Use

10.1038/s41424-018-0074-8 · ExternalCitation · doi-reference

Eosinophilic Esophagitis: A Prevalent Disease in the United States That Affects All Age Groups

10.1053/j.gastro.2008.02.016 · ExternalCitation · doi-reference

Mechanical Properties of the Esophagus in Eosinophilic Esophagitis

10.1053/j.gastro.2010.09.037 · ExternalCitation · doi-reference

Elimination Diet Effectively Treats Eosinophilic Esophagitis in Adults; Food Reintroduction Identifies Causative Factors

10.1053/j.gastro.2012.03.001 · ExternalCitation · doi-reference

Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner

10.1053/j.gastro.2013.08.015 · ExternalCitation · doi-reference

Efficacy of Dietary Interventions for Inducing Histologic Remission in Patients with Eosinophilic Esophagitis: A Systematic Review and Meta-analysis

10.1053/j.gastro.2014.02.006 · ExternalCitation · doi-reference

Development and Validation of a Symptom-Based Activity Index for Adults with Eosinophilic Esophagitis

10.1053/j.gastro.2014.08.028 · ExternalCitation · doi-reference

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults with Eosinophilic Esophagitis

10.1053/j.gastro.2015.11.004 · ExternalCitation · doi-reference

Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared with Placebo in Patients with Eosinophilic Esophagitis

10.1053/j.gastro.2016.11.021 · ExternalCitation · doi-reference

Pathophysiology of Eosinophilic Esophagitis

10.1053/j.gastro.2017.06.065 · ExternalCitation · doi-reference

Epidemiology and Natural History of Eosinophilic Esophagitis

10.1053/j.gastro.2017.06.067 · ExternalCitation · doi-reference

New Eosinophilic Esophagitis Concepts Call for Change in Proton Pump Inhibitor Management Before Diagnostic Endoscopy

10.1053/j.gastro.2018.03.003 · ExternalCitation · doi-reference

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference

10.1053/j.gastro.2018.07.009 · ExternalCitation · doi-reference

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

10.1053/j.gastro.2019.03.025 · ExternalCitation · doi-reference

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults with Active Eosinophilic Esophagitis

10.1053/j.gastro.2019.09.042 · ExternalCitation · doi-reference

Approaches and Challenges to Management of Pediatric and Adult Patients with Eosinophilic Esophagitis

10.1053/j.gastro.2019.09.052 · ExternalCitation · doi-reference

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis

10.1053/j.gastro.2020.02.038 · ExternalCitation · doi-reference

Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters

10.1053/j.gastro.2020.02.039 · ExternalCitation · doi-reference

Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients with Eosinophilic Esophagitis

10.1053/j.gastro.2020.07.039 · ExternalCitation · doi-reference

A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus

10.1053/j.gastro.2021.04.081 · ExternalCitation · doi-reference

Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis

10.1053/j.gastro.2021.06.023 · ExternalCitation · doi-reference

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions

10.1053/j.gastro.2022.03.025 · ExternalCitation · doi-reference

A PhysioMechanical Model of Esophageal Function in Eosinophilic Esophagitis

10.1053/j.gastro.2023.05.031 · ExternalCitation · doi-reference

Determination of a treatment response threshold for the Eosinophilic Esophagitis Endoscopic Reference Score

10.1055/a-1675-7860 · ExternalCitation · doi-reference

Evaluating the Endoscopic Reference Score for eosinophilic esophagitis: Moderate to substantial intra- and interobserver reliability

10.1055/s-0034-1377781 · ExternalCitation · doi-reference

Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis

10.1055/s-0042-107340 · ExternalCitation · doi-reference

Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis

10.1055/s-0042-117274 · ExternalCitation · doi-reference

Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis

10.1055/s-2007-966216 · ExternalCitation · doi-reference

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

10.1056/nejmoa2205982 · ExternalCitation · doi-reference

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

10.1056/nejmoa2313318 · ExternalCitation · doi-reference

Utility of gastric and duodenal biopsy sampling in adult eosinophilic esophagitis patients to rule out other gastrointestinal disorders

10.1080/00365521.2021.1902559 · ExternalCitation · doi-reference

Elimination diets for eosinophilic esophagitis: Making the best choice

10.1080/1744666x.2020.1801419 · ExternalCitation · doi-reference

The role of dupilumab in the treatment of eosinophilic esophagitis

10.1080/1750743x.2024.2377060 · ExternalCitation · doi-reference

What patients with eosinophilic esophagitis may not share with their providers: A qualitative assessment of online health communities

10.1093/dote/doab073 · ExternalCitation · doi-reference

Management of eosinophilic esophagitis associated food impaction in Europe and the United States

10.1093/dote/doac003 · ExternalCitation · doi-reference

Systematic review and meta-regressions: Management of eosinophilic esophagitis requires histologic assessment

10.1093/dote/doy049 · ExternalCitation · doi-reference

Food impaction: Etiology over 35 years and association with eosinophilic esophagitis

10.1093/dote/doy093 · ExternalCitation · doi-reference

Immediate dilation in esophageal food impaction is safe and effective but performed infrequently: Observations from a large Midwest US cohort

10.1093/dote/doz084 · ExternalCitation · doi-reference

Outcome, complication and follow-up of patients with esophageal foreign body impaction: An academic institute’s 15 years of experience

10.1093/dote/doz103 · ExternalCitation · doi-reference

Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases

10.1097/mcg.0000000000001629 · ExternalCitation · doi-reference

Corticosteroid-dependent eosinophilic oesophagitis: Azathioprine and 6-mercaptopurine can induce and maintain long-term remission

10.1097/meg.0b013e32825a6ab4 · ExternalCitation · doi-reference

The role of the allergist in the management of eosinophilic esophagitis

10.1097/mog.0000000000000746 · ExternalCitation · doi-reference

Dilation of Pediatric Eosinophilic Esophagitis

10.1097/mpg.0000000000001336 · ExternalCitation · doi-reference

Eosinophilic Esophagitis Histology Remission Score

10.1097/mpg.0000000000002637 · ExternalCitation · doi-reference

Treatment with High-dose Proton Pump Inhibitors Helps Distinguish Eosinophilic Esophagitis From Noneosinophilic Esophagitis

10.1097/mpg.0b013e31819c4b3e · ExternalCitation · doi-reference

Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis

10.1111/all.12096 · ExternalCitation · doi-reference

Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993–2013: A population-based study

10.1111/all.12733 · ExternalCitation · doi-reference

Detergent exposure induces epithelial barrier dysfunction and eosinophilic inflammation in the esophagus

10.1111/all.15457 · ExternalCitation · doi-reference

Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia

10.1111/apt.12977 · ExternalCitation · doi-reference

Seasonal variation in detection of oesophageal eosinophilia and eosinophilic oesophagitis

10.1111/apt.13273 · ExternalCitation · doi-reference

The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia

10.1111/apt.13496 · ExternalCitation · doi-reference

Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities

10.1111/apt.13676 · ExternalCitation · doi-reference

The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon

10.1111/apt.13718 · ExternalCitation · doi-reference

Systematic review with meta-analysis: Endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis

10.1111/apt.14123 · ExternalCitation · doi-reference

Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes

10.1111/apt.15000 · ExternalCitation · doi-reference

Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: Results from the EoE connect registry

10.1111/apt.15957 · ExternalCitation · doi-reference

Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction

10.1111/apt.17101 · ExternalCitation · doi-reference

Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: An integrated safety analysis of six phase 1–3 clinical trials

10.1111/apt.17430 · ExternalCitation · doi-reference

Development of a model to identify patients who do not need oesophageal biopsies when eosinophilic oesophagitis is suspected

10.1111/apt.17772 · ExternalCitation · doi-reference

Oesophageal eosinophilic infiltration in patients with noncardiac chest pain

10.1111/j.1365-2036.2011.04652.x · ExternalCitation · doi-reference

The adult eosinophilic oesophagitis quality of life questionnaire: A new measure of health-related quality of life

10.1111/j.1365-2036.2011.04791.x · ExternalCitation · doi-reference

Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: A historical cohort

10.1111/j.1398-9995.2012.02881.x · ExternalCitation · doi-reference

Safety of dilation in adults with eosinophilic esophagitis

10.1111/j.1442-2050.2012.01363.x · ExternalCitation · doi-reference

Eosinophils in the Esophagus—Peptic or Allergic Eosinophilic Esophagitis? Case Series of Three Patients with Esophageal Eosinophilia

10.1111/j.1572-0241.2006.00562.x · ExternalCitation · doi-reference

Evaluation of esophageal distensibility in eosinophilic esophagitis: An update and comparison of functional lumen imaging probe analytic methods

10.1111/nmo.12888 · ExternalCitation · doi-reference

Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance

10.1111/nmo.13919 · ExternalCitation · doi-reference

Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0 ©

10.1111/nmo.14058 · ExternalCitation · doi-reference

Recognising eosinophilic oesophagitis as a cause of food bolus obstruction

10.1136/flgastro-2019-101176 · ExternalCitation · doi-reference

Eosinophilic oesophagitis: A novel treatment using Montelukast

10.1136/gut.52.2.181 · ExternalCitation · doi-reference

Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: Validation of a novel classification and grading system

10.1136/gutjnl-2011-301817 · ExternalCitation · doi-reference

Proton pump inhibitor-responsive oesophageal eosinophilia: An entity challenging current diagnostic criteria for eosinophilic oesophagitis

10.1136/gutjnl-2015-310991 · ExternalCitation · doi-reference

British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults

10.1136/gutjnl-2022-327326 · ExternalCitation · doi-reference

Comparison of drugs for active eosinophilic oesophagitis: Systematic review and network meta-analysis

10.1136/gutjnl-2023-329873 · ExternalCitation · doi-reference

The Potential Impact of Contemporary Developments in the Management of Patients with Gastroesophageal Reflux Disease Undergoing an Initial Gastroscopy

10.1155/2009/859271 · ExternalCitation · doi-reference

Routine screening for eosinophilic esophagitis in patients presenting with dysphagia

10.1177/1756283x10384172 · ExternalCitation · doi-reference

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: A review of the latest evidence

10.1177/1756284820927282 · ExternalCitation · doi-reference

Eosinophilic esophagitis: Clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults

10.1177/1756284820980860 · ExternalCitation · doi-reference

Guidelines on eosinophilic esophagitis: Evidence-based statements and recommendations for diagnosis and management in children and adults

10.1177/2050640616689525 · ExternalCitation · doi-reference

Eosinophilic esophagitis

10.1186/s13223-018-0287-0 · ExternalCitation · doi-reference

Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: A Delphi consensus project

10.1186/s13223-025-00993-0 · ExternalCitation · doi-reference

Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension

10.1186/s41687-017-0006-5 · ExternalCitation · doi-reference

S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents with EoE

10.14309/01.ajg.0000858424.48968.ad · ExternalCitation · doi-reference

S2867 Refractory Adult Fibrostenotic Phenotype Eosinophilic Esophagitis Treated with Dupilumab

10.14309/01.ajg.0000961108.34163.af · ExternalCitation · doi-reference

S4273 Dupilumab Increases Esophageal Diameter in 2 Patients with Refractory Fibrostenotic Eosinophilic Esophagitis

10.14309/01.ajg.0001144552.91731.43 · ExternalCitation · doi-reference

Mast Cell Infiltration Is Associated with Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis

10.14309/ajg.0000000000000474 · ExternalCitation · doi-reference

ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease

10.14309/ajg.0000000000001538 · ExternalCitation · doi-reference

Poor Adherence to Medical and Dietary Treatments in Adult Patients with Eosinophilic Esophagitis

10.14309/ajg.0000000000001850 · ExternalCitation · doi-reference

Efficacy of a Second PPI Course After Steroid-Induced Remission in Eosinophilic Esophagitis Refractory to Initial PPI Therapy

10.14309/ajg.0000000000001943 · ExternalCitation · doi-reference

Six-Food Elimination Diet Is Less Effective During Pollen Season in Adults with Eosinophilic Esophagitis Sensitized to Pollens

10.14309/ajg.0000000000002357 · ExternalCitation · doi-reference

ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis

10.14309/ajg.0000000000003194 · ExternalCitation · doi-reference

10.1684/hpg.2024.2802

10.1684/hpg.2024.2802 · ExternalCitation · doi-reference

The Risk of Esophageal Food Impaction in Eosinophilic Esophagitis Patients: The Role of Clinical and Socioeconomic Factors

10.2147/ceg.s364994 · ExternalCitation · doi-reference

Expert Opinion on the Management, Challenges, and Knowledge Gaps Pertaining to Eosinophilic Esophagitis Among Adults in the Greater Gulf Region

10.2147/ceg.s511469 · ExternalCitation · doi-reference

Anxiety and Depression in Eosinophilic Esophagitis: A Scoping Review and Recommendations for Future Research

10.2147/jaa.s193045 · ExternalCitation · doi-reference

The Role of Food Allergy in Eosinophilic Esophagitis

10.2147/jaa.s238565 · ExternalCitation · doi-reference

10.3389/fphys.2021.815842

10.3389/fphys.2021.815842 · ExternalCitation · doi-reference

10.3390/diagnostics13172806

10.3390/diagnostics13172806 · ExternalCitation · doi-reference

10.3390/ijms242015165

10.3390/ijms242015165 · ExternalCitation · doi-reference

10.3390/ijms25073685

10.3390/ijms25073685 · ExternalCitation · doi-reference

10.3390/nu13051630

10.3390/nu13051630 · ExternalCitation · doi-reference

Can artificial intelligence improve the diagnosis and management of patients with eosinophilic esophagitis?

10.3748/wjg.v31.i38.110999 · ExternalCitation · doi-reference